COVIR

COVIR

Created using Figma
Octopusrobots, a company listed on the stock exchange on Access, filed a patent on February 7, 2017 PCT / FR2017 / 050277 (valid for 20 years i.e. 2037) and is developing a technology for air disinfection (spray) of spaces and surfaces potentially contaminated by viruses e.g. Covid-19, or bacteria.
The global containment measures do not allow to classically negotiate "face to face" with Asian, Russian, US customers etc… and the financing being very urgent and important to industrialize quickly it was decided to use digital methods to strengthen the effectiveness of financing implementations and finding resources and solutions outside of conventional financial systems (banks, funds, etc.)
In partnership with COVIR.IO operational pre-financing vehicle; Octopusrobots launches the prefinancing of its global portfolio of
potential licenses by TOKENIZING ITS LICENSING RIGHTS ON THE TEZOS BLOCKCHAIN. The solution is up and running since 2015. Octopus robots is already 20 years old.
Data is not available
Mar 10, 2020
Aug 1, 2020
100% completed
Raised funds - no Data
Goal 4 000 000.00 USD
Cap 4 000 000.00 USD
past
  • 1 CVR
    =
    0.2 USD
Token Details
Ticker
CVR
Total supply
400000000
Accepted Currencies
XTZ, ETH, BTC, USD, TRX
Min Contribution
50
USD
Company Details
Registered Company Name
Pagest Environnement
Registered Country
Switzerland
Additional Details
MVP/Prototype
Yes
Platform
Tezos
Categories
Platform

About COVIR

Covir is a platform that is designed to fund biosafety projects and licenses using blockchain technology. Biosafety licenses funded by Covir are for Octopus robots products; Octopus robots design biosafety equipment that decontaminates large buildings such as shopping malls, airport terminals, and food processing plants. Without a doubt, Covir project is the best blockchain project to invest in because biosafety projects are currently underrepresented in the blockchain world, despite there being a lot of opportunities in the biosafety industry. The current ravaging COVID-19 pandemic has accelerated the need for biosafety equipment.

COVIR Roadmap

  • RoadMap for 2020 v1.2

  • https://covir.fr/wp-content/uploads/2020/document/CovirRoadMap2020-v1.2.pdf

COVIR Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

William Baude
Deputy Director - Data R&D - CTO Expert Crypto
unverified
Zied Chaabane
Arabic Manager & Project Manager
unverified

COVIR Last News

  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.